Brief: Index Pharmaceuticals To Present Successful Results Of Conduct Study
Aug 24 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* INDEX PHARMACEUTICALS TO PRESENT THE SUCCESSFUL RESULTS OF
THE
CONDUCT STUDY AT TWO LEADING MEDICAL CONFERENCES
* STUDY MET PRIMARY ENDPOINT WITH AN OUTSTANDING COMBINATION
OF
EFFICACY AND SAFETY.
Source text for Eikon: ID:nWkr89PcWs
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen